Open AccessThiazolidinediones and risk of colorectal cancer in patients with diabetes mellitus: A meta-analysis
Author(s) -
Yang Liu,
Piaopiao Jin,
Xuecheng Sun,
Tingting Hu
Publication year - 2018
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/sjg.sjg_295_17
Subject(s) - medicine , pioglitazone , relative risk , meta analysis , colorectal cancer , subgroup analysis , confidence interval , population , diabetes mellitus , cohort study , lower risk , oncology , gastroenterology , cancer , type 2 diabetes , endocrinology , environmental health
A growing body of evidence has suggested that thiazolidinediones (TZDs) potentially reduce the risk of colorectal cancer (CRC). This study aimed to evaluate the effect of TZDs on CRC risk in patients with diabetes mellitus (DM).